- Home
- POLA vs KTTA Comparison
POLA vs KTTA Comparison
Compare POLA & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- KTTA
- Stock Information
- Founded
- POLA 1979
- KTTA 2020
- Country
- POLA United States
- KTTA United States
- Employees
- POLA N/A
- KTTA N/A
- Industry
- POLA Industrial Machinery/Components
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- POLA Miscellaneous
- KTTA Health Care
- Exchange
- POLA Nasdaq
- KTTA Nasdaq
- Market Cap
- POLA 5.2M
- KTTA 5.5M
- IPO Year
- POLA 2016
- KTTA 2021
- Fundamental
- Price
- POLA $2.69
- KTTA $0.72
- Analyst Decision
- POLA
- KTTA
- Analyst Count
- POLA 0
- KTTA 0
- Target Price
- POLA N/A
- KTTA N/A
- AVG Volume (30 Days)
- POLA 909.7K
- KTTA 203.1K
- Earning Date
- POLA 11-13-2025
- KTTA 11-12-2025
- Dividend Yield
- POLA N/A
- KTTA N/A
- EPS Growth
- POLA N/A
- KTTA N/A
- EPS
- POLA N/A
- KTTA N/A
- Revenue
- POLA $11,967,000.00
- KTTA N/A
- Revenue This Year
- POLA N/A
- KTTA N/A
- Revenue Next Year
- POLA N/A
- KTTA N/A
- P/E Ratio
- POLA N/A
- KTTA N/A
- Revenue Growth
- POLA 0.14
- KTTA N/A
- 52 Week Low
- POLA $1.53
- KTTA $0.65
- 52 Week High
- POLA $4.69
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- POLA 62.21
- KTTA 43.16
- Support Level
- POLA $2.26
- KTTA $0.74
- Resistance Level
- POLA $3.67
- KTTA $0.81
- Average True Range (ATR)
- POLA 0.34
- KTTA 0.06
- MACD
- POLA 0.02
- KTTA -0.01
- Stochastic Oscillator
- POLA 39.88
- KTTA 11.45
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).